234 related articles for article (PubMed ID: 20523244)
41. [Neuro-cardio-facial-cutaneous syndrome].
Bessis D
Ann Dermatol Venereol; 2011; 138(6-7):483-93. PubMed ID: 21700069
[TBL] [Abstract][Full Text] [Related]
42. Tetralogy of Fallot and hypertrophic cardiomyopathy in a case of cardiofaciocutaneous syndrome.
Yildirim SV; Kale-Cekinmez E; Ozcan D; Derbent M
Turk J Pediatr; 2008; 50(3):275-7. PubMed ID: 18773675
[TBL] [Abstract][Full Text] [Related]
43. Cardio-facio-cutaneous (CFC) syndrome: report of a new patient.
Chrzanowska K; Fryns JP; Van den Berghe H
Am J Med Genet; 1989 Aug; 33(4):471-3. PubMed ID: 2596505
[TBL] [Abstract][Full Text] [Related]
44. Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras/MAPK pathway.
Garg S; Brooks A; Burns A; Burkitt-Wright E; Kerr B; Huson S; Emsley R; Green J
Dev Med Child Neurol; 2017 May; 59(5):544-549. PubMed ID: 28160302
[TBL] [Abstract][Full Text] [Related]
45. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Schulz AL; Albrecht B; Arici C; van der Burgt I; Buske A; Gillessen-Kaesbach G; Heller R; Horn D; Hübner CA; Korenke GC; König R; Kress W; Krüger G; Meinecke P; Mücke J; Plecko B; Rossier E; Schinzel A; Schulze A; Seemanova E; Seidel H; Spranger S; Tuysuz B; Uhrig S; Wieczorek D; Kutsche K; Zenker M
Clin Genet; 2008 Jan; 73(1):62-70. PubMed ID: 18042262
[TBL] [Abstract][Full Text] [Related]
46. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
[TBL] [Abstract][Full Text] [Related]
47. Cardiofaciocutaneous syndrome - a longitudinal study of a case over 33 years: case report and review of the literature.
Jurcă MC; Iuhas OA; Puiu M; Chiriţă-Emandi A; Andreescu NI; Petcheşi CD; Jurcă AD; Magyar I; Jurcă SI; Kozma K; Severin EM; Bembea M
Rom J Morphol Embryol; 2021; 62(2):563-568. PubMed ID: 35024745
[TBL] [Abstract][Full Text] [Related]
48. A girl with Cardio-facio-cutaneous syndrome complicated with status epilepticus and acute encephalopathy.
Wakusawa K; Kobayashi S; Abe Y; Tanaka S; Endo W; Inui T; Iwaki M; Watanabe S; Togashi N; Nara T; Niihori T; Aoki Y; Haginoya K
Brain Dev; 2014 Jan; 36(1):61-3. PubMed ID: 23340054
[TBL] [Abstract][Full Text] [Related]
49. Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: developmental consequences of germline Ras/MAPK activation on myogenesis.
Tidyman WE; Lee HS; Rauen KA
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):104-14. PubMed ID: 21495178
[TBL] [Abstract][Full Text] [Related]
50. Clinical Report: Cognitive decline in a patient with Cardiofaciocutaneous syndrome.
Cabrera S; Morel C; Tartaglia MC
Am J Med Genet A; 2016 May; 170A(5):1251-6. PubMed ID: 26842671
[TBL] [Abstract][Full Text] [Related]
51. Clinical and molecular spectra of BRAF-associated RASopathy.
Lee Y; Choi Y; Seo GH; Kim GH; Choi IH; Keum C; Ko JM; Cheon CK; Jeon J; Choi JH; Yoo HW; Lee BH
J Hum Genet; 2021 Apr; 66(4):389-399. PubMed ID: 33040082
[TBL] [Abstract][Full Text] [Related]
52. The perinatal presentation of cardiofaciocutaneous syndrome.
Wong Ramsey KN; Loichinger MH; Slavin TP; Kuo S; Seaver LH
Am J Med Genet A; 2014 Aug; 164A(8):2036-42. PubMed ID: 24719372
[TBL] [Abstract][Full Text] [Related]
53. Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice.
Inoue SI; Takahara S; Yoshikawa T; Niihori T; Yanai K; Matsubara Y; Aoki Y
Hum Mol Genet; 2017 Dec; 26(23):4715-4727. PubMed ID: 28973166
[TBL] [Abstract][Full Text] [Related]
54. Ras/MAPK dysregulation in development causes a skeletal myopathy in an activating Braf
Maeda Y; Tidyman WE; Ander BP; Pritchard CA; Rauen KA
Dev Dyn; 2021 Aug; 250(8):1074-1095. PubMed ID: 33522658
[TBL] [Abstract][Full Text] [Related]
55. Brain structural changes in patients with cardio-facio-cutaneous syndrome: effects of BRAF gene mutation and epilepsy on brain development. A case-control study by quantitative magnetic resonance imaging.
Calandrelli R; Pilato F; Panfili M; Battaglia D; Gambardella ML; Colosimo C
Neuroradiology; 2022 Jan; 64(1):185-195. PubMed ID: 34309696
[TBL] [Abstract][Full Text] [Related]
56. CNS imaging is a key diagnostic tool in the evaluation of patients with CFC syndrome: two cases and literature review.
Papadopoulou E; Sifakis S; Sol-Church K; Klein-Zighelboim E; Stabley DL; Raissaki M; Gripp KW; Kalmanti M
Am J Med Genet A; 2011 Mar; 155A(3):605-11. PubMed ID: 21337689
[TBL] [Abstract][Full Text] [Related]
57. Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study.
Pierpont EI; Kenney-Jung DL; Shanley R; Zatkalik AL; Whitmarsh AE; Kroening SJ; Roberts AE; Zenker M
Genet Med; 2022 Jul; 24(7):1556-1566. PubMed ID: 35524774
[TBL] [Abstract][Full Text] [Related]
58.
Aoidi R; Houde N; Landry-Truchon K; Holter M; Jacquet K; Charron L; Krishnaswami SR; Yu BD; Rauen KA; Bisson N; Newbern J; Charron J
Dis Model Mech; 2018 Mar; 11(3):. PubMed ID: 29590634
[TBL] [Abstract][Full Text] [Related]
59. Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome.
Ion A; Tartaglia M; Song X; Kalidas K; van der Burgt I; Shaw AC; Ming JE; Zampino G; Zackai EH; Dean JC; Somer M; Parenti G; Crosby AH; Patton MA; Gelb BD; Jeffery S
Hum Genet; 2002 Oct; 111(4-5):421-7. PubMed ID: 12384786
[TBL] [Abstract][Full Text] [Related]
60. Cardio
Chen B; Chen S; Xiong J; Yin F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):432-437. PubMed ID: 33967092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
